Custom-Made vaccine targets each Patient's unique cancer mutations
NCT ID NCT06614140
First seen Apr 25, 2026 · Last updated May 15, 2026 · Updated 4 times
Summary
This study tested a personalized vaccine made from each patient's unique cancer mutations (neoantigens) in 8 adults with advanced solid tumors or high risk of recurrence. The vaccine aims to train the immune system to recognize and attack cancer cells. Researchers checked for safety and immune responses, offering a potential new option for patients with limited treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vejthani Hospital
Bangkok, 10240, Thailand
Conditions
Explore the condition pages connected to this study.